Literature DB >> 19336275

MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4.

Yunhui Cheng1, Xiaojun Liu, Shuo Zhang, Ying Lin, Jian Yang, Chunxiang Zhang.   

Abstract

Reactive oxygen species (ROS)-induced cardiac cell injury via expression changes of multiple genes plays a critical role in the pathogenesis of numerous heart diseases. MicroRNAs (miRNAs) comprise a novel class of endogenous, small, noncoding RNAs that negatively regulate about 30% of the genes in a cell via degradation or translational inhibition of their target mRNAs. Currently, the effects of ROS on miRNA expression and the roles of miRNAs in ROS-mediated injury on cardiac myocytes are uncertain. Using quantitative real-time RT-PCR (qRT-PCR), we demonstrated that microRNA-21 (miR-21) was upregulated in cardiac myocytes after treatment with hydrogen peroxide (H(2)O(2)). To determine the potential roles of miRNAs in H(2)O(2)-mediated gene regulation and cellular injury, miR-21 expression was downregulated by miR-21 inhibitor and upregulated by pre-miR-21. H(2)O(2)-induced cardiac cell death and apoptosis were increased by miR-21 inhibitor and was decreased by pre-miR-21. Programmed cell death 4 (PDCD4) that was regulated by miR-21 and was a direct target of miR-21 in cardiac myocytes. Pre-miR-21-mediated protective effect on cardiac myocyte injury was inhibited in H(2)O(2)-treated cardiac cells via adenovirus-mediated overexpression of PDCD4 without miR-21 binding site. Moreover, Activator protein 1 (AP-1) was a downstream signaling molecule of PDCD4 that was involved in miR-21-mediated effect on cardiac myocytes. The results suggest that miR-21 is sensitive to H(2)O(2) stimulation. miR-21 participates in H(2)O(2)-mediated gene regulation and functional modulation in cardiac myocytes. miR-21 might play an essential role in heart diseases related to ROS such as cardiac hypertrophy, heart failure, myocardial infarction, and myocardial ischemia/reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336275      PMCID: PMC3593965          DOI: 10.1016/j.yjmcc.2009.01.008

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  36 in total

Review 1.  AP-1: linking hydrogen peroxide and oxidative stress to the control of cell proliferation and death.

Authors:  M Karin; E Shaulian
Journal:  IUBMB Life       Date:  2001-07       Impact factor: 3.885

Review 2.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 3.  MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing.

Authors:  Victor Ambros
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

4.  Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation.

Authors:  Hsin-Sheng Yang; Jennifer L Knies; Cristi Stark; Nancy H Colburn
Journal:  Oncogene       Date:  2003-06-12       Impact factor: 9.867

Review 5.  Oxidative stress and cardiac disease.

Authors:  D J Lefer; D N Granger
Journal:  Am J Med       Date:  2000-09       Impact factor: 4.965

6.  Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells.

Authors:  Andrea L Weigel; James T Handa; Leonard M Hjelmeland
Journal:  Free Radic Biol Med       Date:  2002-11-15       Impact factor: 7.376

Review 7.  AP-1 in cell proliferation and survival.

Authors:  E Shaulian; M Karin
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

8.  The intervening sequence RNA of Tetrahymena is an enzyme.

Authors:  A J Zaug; T R Cech
Journal:  Science       Date:  1986-01-31       Impact factor: 47.728

Review 9.  Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes.

Authors:  Abdelkarim Sabri; Hoyt H Hughie; Pamela A Lucchesi
Journal:  Antioxid Redox Signal       Date:  2003-12       Impact factor: 8.401

Review 10.  Oxidative stress-induced signal transduction pathways in cardiac myocytes: involvement of ROS in heart diseases.

Authors:  Hiroyuki Takano; Yunzeng Zou; Hiroshi Hasegawa; Hiroshi Akazawa; Toshio Nagai; Issei Komuro
Journal:  Antioxid Redox Signal       Date:  2003-12       Impact factor: 8.401

View more
  167 in total

Review 1.  Have tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue?

Authors:  Matthew R Young; Arti N Santhanam; Noriko Yoshikawa; Nancy H Colburn
Journal:  Mol Interv       Date:  2010-04

Review 2.  microRNAs in heart disease: putative novel therapeutic targets?

Authors:  Gianluigi Condorelli; Michael V G Latronico; Gerald W Dorn
Journal:  Eur Heart J       Date:  2010-01-29       Impact factor: 29.983

Review 3.  The redox basis of epigenetic modifications: from mechanisms to functional consequences.

Authors:  Anthony R Cyr; Frederick E Domann
Journal:  Antioxid Redox Signal       Date:  2011-02-05       Impact factor: 8.401

Review 4.  Regulation of mammalian microRNA expression.

Authors:  Xiaoxiao Zhang; Yan Zeng
Journal:  J Cardiovasc Transl Res       Date:  2010-02-20       Impact factor: 4.132

Review 5.  miRNAs as therapeutic targets in ischemic heart disease.

Authors:  Robert J A Frost; Eva van Rooij
Journal:  J Cardiovasc Transl Res       Date:  2010-03-30       Impact factor: 4.132

Review 6.  Biological functions of microRNAs: a review.

Authors:  Yong Huang; Xing Jia Shen; Quan Zou; Sheng Peng Wang; Shun Ming Tang; Guo Zheng Zhang
Journal:  J Physiol Biochem       Date:  2010-10-28       Impact factor: 4.158

Review 7.  Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction.

Authors:  Christian Schulte; Dirk Westermann; Stefan Blankenberg; Tanja Zeller
Journal:  World J Cardiol       Date:  2015-12-26

8.  Overexpression of microRNA-145 protects against rat myocardial infarction through targeting PDCD4.

Authors:  Hao Xu; Heng Cao; Guoqing Zhu; Shaowen Liu; Hongli Li
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 9.  MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.

Authors:  V Sala; S Bergerone; S Gatti; S Gallo; A Ponzetto; C Ponzetto; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

10.  microRNA-21 promotes cardiac fibrosis and development of heart failure with preserved left ventricular ejection fraction by up-regulating Bcl-2.

Authors:  Shuguang Dong; Wenhan Ma; Bohan Hao; Fen Hu; Lianhua Yan; Xiaofei Yan; Ya Wang; Zhijian Chen; Zhaohui Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.